http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-062684-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4fda45c540f11df3a7fe71d54a70562a |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 |
| filingDate | 2007-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2008-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-062684-A1 |
| titleOfInvention | COMPOUNDS DERIVED FROM PIRIDIN-3- ILO, PHARMACEUTICAL COMPOSITION CONTAINING THEM, AND USE OF THE SAME IN THE PREPARATION OF MEDICINES |
| abstract | Such compounds act particularly as immunomodulating agents. Claim 1: A compound of Formula (1) wherein A represents * -CONH-CH2-, * -CO-CH = CH-, * -CO-CH2CH2-, group of formulas (2) where the asterisks indicate the bond where it binds to the pyridine group of Formula 1; R1 represents hydrogen, C1-4-alkyl, or chlorine; R2 represents C1-5-alkyl or C1-4-alkoxy; R3 represents hydrogen, C1-4-alkyl, C1-4alkoxy, or halogen; R4 represents hydrogen, C1-4-alkyl, C1-4-alkoxy, halogen, trifluoromethyl or trifluoromethoxy; R5 represents 2,3-dihydroxypropyl, di- (hydroxy-C1-4-alkyl) -C1-4-alkyl, -CH2- (CH2) kNHSO2R53, - (CH2) nCH (OH) -CH2-NHSO2R53, -CH2- (CH2) k-NHCOR54, - (CH2) nCH (OH) -CH2-NHCOR54, -CH2- (CH2) n-CONR51R52, -CO- NHR51, 1- (3-carboxy-azetidinyl) -2-acetyl, 1 - (2-carboxy-pyrrolidinyl) -2-acetyl, 1- (3-carboxy-pyrrolidinyl) -2-acetyl, 1- (3-carboxy-azetidinyl) -3-propionyl, 1- (2-carboxy-pyrrolidinyl) -3-propionyl, 1- (3-carboxy-pyrrolidinyl) -3-propionyl, - (CH2) nCH (OH) - CH2-NR51R52, hydroxy, hydroxy-C2-5-alkoxy, di- (hydroxy-C1-4 -alkyl) -C1-4-alkoxy, 2,3-dihydroxy-propoxy, 2-hydroxy-3-methoxy-propoxy, -OCH2- (CH2) m-NR51R52, 2 - [(azetidine-3-carboxylic acid) - 1-yl] -ethoxy, 2 - [(azetidine-3-C1-5 carboxylic acid) -1-yl] -ethoxy, 2 - [(pyrrolidine-3-carboxylic acid) -1-yl] -ethoxy, 2 - [(Pyrrolidine-3-C1-5-alkyl ester carboxylic acid) -1-yl] -ethoxy, -OCH2-CH (OH) -CH2-NR51R52, 3 - [(azetidine-3-carboxylic acid) -1- il] -2-hydroxypropoxy, 3 - [(azetidine-3-C1-5-alkyl ester carboxylic acid) -1-yl] -2-hydroxy ropoxy, 2-hydroxy-3 - [(pyrrolidine-3-carboxylic acid) -1-yl] -propoxy, 2-hydroxy-3 - [(pyrrolidine-3- C1-5-alkyl ester carboxylic acid) -1-yl] propoxy, 2-hydroxy-3 - [(pyrrolidine-2- carboxylic acid) -1-yl] -propoxy, 2-hydroxy-3 - [(pyrrolidine-2- C1-5-alkyl ester carboxylic acid) -1-yl] -propoxy, -OCH2- (CH2) m-NHSO2R53, -OCH2-CH (OH) -CH2-NHSO2R53, -OCH2- (CH2) m-NHCOR54, -OCH2-CH (OH) -CH2-NHCOR54; R51 represents hydrogen, C1-3-alkyl, 2-hydroxyethyl, 2- hydroxy-1-hydroxymethyl-ethyl, 2,3-dihydroxypropyl, carboxymethyl, 1- (C1-5-alkylcarboxy) methyl, 2-carboxy-ethyl, or 2- (C1-5-alkylcarboxy) ethyl; R52 represents hydrogen, methyl, or ethyl; R53 represents C1-3-alkyl, methylamino, ethylamino, or dimethylamino; R54 represents hydroxymethyl, hydroxyethyl, aminomethyl, methylaminomethyl, dimethylaminomethyl, aminoethyl, 2-methylaminoethyl, or 2-dimethylaminoethyl; k represents the integer 1, 2, or 3; m represents the whole number 1 or 2; n represents 0, 1, or 2; and R6 represents hydrogen, C1-4-alkyl or halogen, and a salt of such a compound. |
| priorityDate | 2006-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 62.